EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How Does Platelet Dysfunction Affect CMD Risk Across Age, Sex, and BMI Groups: A Comprehensive Review

Seher Adnan, Tisa Shah, Rahaf Zeidan

Undergraduate Research in Natural and Clinical Science and Technology Journal · 28.10.2026 · 1-9

DOI: 10.26685/urncst.1098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Undergraduate Research in Natural and Clinical Science and Technology Journal, online erschienen am 28.10.2026. Verfasst von Seher Adnan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiometabolic diseases (CMD) are a group of interconnected metabolic and cardiovascular disorders influenced by genetic, environmental, and lifestyle factors, representing a major cause of global mortality [1]. Metabolic dysfunctions such as obesity, type 2 diabetes, and dyslipidemia contribute to vascular complications including heart failure and hypertension [2]. Recent studies identify platelet dysfunction as a key mediator linking metabolic dysregulation, inflammation, and thrombosis [3]. Platelets are anucleate fragments derived from megakaryocytes that maintain vascular integrity through hemostasis and thrombus formation [4]. Under metabolic stress conditions such as hyperglycemia and oxidative stress, platelets become aberrantly activated, exhibiting enhanced adhesion, aggregation, and cytokine secretion [3]. Due to limited data on platelet-based studies assessing CMD risk variables [5], we hypothesized that platelet activation markers would amongst males, older individuals, and those with a high BMI. This investigation therefore aims to evaluate the correlation of platelet activation markers with CMD risk across demographic groups, clarifying their role as potential early biomarkers of CMD progression.

Methods

This comprehensive review categorized a variety of studies regarding platelet biomarkers and their roles in cell-signalling pathways by sex, BMI, patient/control, and age groups. Statistical associations were correlated between biomarkers of interest including P-selectin, soluble CD40 ligand (sCD40L) platelet-derived extracellular vesicles (pEV), mean platelet volume (MPV), platelet phospholipid eicosapentaenoic acid (EPA) fraction, and the cardiometabolic outcomes they produce. Statistical analyses included multivariate linear regression models to identify independent predictors of CMD risk, furthermore analysis of variance (ANOVA) to test group differences, using a significance of p

Zitieren

APA

Adnan, S., Shah, T., & Zeidan, R. (2026). How Does Platelet Dysfunction Affect CMD Risk Across Age, Sex, and BMI Groups: A Comprehensive Review. Undergraduate Research in Natural and Clinical Science and Technology Journal, 1-9. https://doi.org/10.26685/urncst.1098

Vancouver

Adnan S, Shah T, Zeidan R. How Does Platelet Dysfunction Affect CMD Risk Across Age, Sex, and BMI Groups: A Comprehensive Review. Undergraduate Research in Natural and Clinical Science and Technology Journal. 2026:1-9. doi:10.26685/urncst.1098

BibTeX
@article{Adnan2026,
  author = {Adnan, Seher and Shah, Tisa and Zeidan, Rahaf},
  title = {How Does Platelet Dysfunction Affect CMD Risk Across Age, Sex, and BMI Groups: A Comprehensive Review},
  journal = {Undergraduate Research in Natural and Clinical Science and Technology Journal},
  year = {2026},
  pages = {1--9},
  doi = {10.26685/urncst.1098}
}
Kostenlos starten →